These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2785444)

  • 61. [Susceptibility and beta-lactamase-producing strains of methicillin-resistant Staphylococcus aureus].
    Akimoto Y; Kaneko K; Fujii A
    Nichidai Koko Kagaku; 1989 Sep; 15(3):338-41. PubMed ID: 2489806
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Distant and new mutations in CTX-M-1 beta-lactamase affect cefotaxime hydrolysis.
    Pérez-Llarena FJ; Kerff F; Abián O; Mallo S; Fernández MC; Galleni M; Sancho J; Bou G
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4361-8. PubMed ID: 21730121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ceftazidime: in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Phillips I; Warren C; Shannon K; King A; Hanslo D
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():23-31. PubMed ID: 19802967
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus.
    Regamey C; Libke RD; Engelking ER; Clarke JT; Kirby MM
    J Infect Dis; 1975 Mar; 131(3):291-4. PubMed ID: 1039311
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Novel Insights into the Classification of Staphylococcal β-Lactamases in Relation to the Cefazolin Inoculum Effect.
    Carvajal LP; Rincon S; Echeverri AM; Porras J; Rios R; Ordoñez KM; Seas C; Gomez-Villegas SI; Diaz L; Arias CA; Reyes J
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071048
    [TBL] [Abstract][Full Text] [Related]  

  • 66. CTX and its desacetyl derivative (des-CTX): interaction with some representative beta-lactamases and their related pattern of resistance to newer selected clinical isolates.
    Amicosante G; Perilli M; Felici A; Segatore B; Franceschini N; Basani F; Di Girolamo M; Oratore A
    Drugs Exp Clin Res; 1990; 16(11):549-56. PubMed ID: 2101778
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Activity of clavulanate-potentiated penicillins against methicillin-resistant Staphylococcus aureus.
    Graninger W; Leitha T; Griffin K; Witte W; Svacina W
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():49-54. PubMed ID: 2606819
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Characterization of four beta-lactamases produced by Staphylococcus aureus.
    Zygmunt DJ; Stratton CW; Kernodle DS
    Antimicrob Agents Chemother; 1992 Feb; 36(2):440-5. PubMed ID: 1605608
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In vitro antibacterial activity of cefotaxime and desacetylcefotaxime, alone or in combination, against gram-positive cocci.
    Cruciani M; Navarra A; Di Perri G; Danzi MC; Concia E; Bassetti D
    Drugs Exp Clin Res; 1990; 16(11):565-8. PubMed ID: 2101779
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of beta-lactamase of methicillin-susceptible Staphylococcus aureus in resistance to first-generation oral cephems both in vitro and in vivo.
    Takenouchi T; Utsui Y; Ohya S; Nishino T
    J Antimicrob Chemother; 1994 Dec; 34(6):909-20. PubMed ID: 7730234
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Modification of homogeneous resistance in a methicillin-resistant strain of Staphylococcus aureus by acquisition of a beta-lactamase encoding plasmid.
    Opal SM; Boyce JM; Medeiros AA; Mayer KH; Lyhte LW
    J Antimicrob Chemother; 1989 Mar; 23(3):315-25. PubMed ID: 2499563
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Enhancement of in vitro antimicrobial activity of cefmetazole and cefazolin in combination against methicillin-resistant Staphylococcus aureus studies by checkerboard MIC method and disc diffusion method using discs containing both drugs].
    Matsuo K; Uete T
    Jpn J Antibiot; 1993 Feb; 46(2):130-41. PubMed ID: 8331773
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The beta-lactamase stability of amoxycillin with the beta-lactamase inhibitor, clavulanic acid.
    Reading C; Farmer T; Cole M
    J Antimicrob Chemother; 1983 Jan; 11(1):27-32. PubMed ID: 6600741
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation.
    Chapman SW; Steigbigel RT
    J Infect Dis; 1983 Jun; 147(6):1078-89. PubMed ID: 6602190
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clavulanic acid in combination with ticarcillin: an in-vitro comparison with other beta-lactams.
    Clarke AM; Zemcov SJ
    J Antimicrob Chemother; 1984 Feb; 13(2):121-8. PubMed ID: 6323375
    [TBL] [Abstract][Full Text] [Related]  

  • 76. beta-Lactamase-mediated inactivation and efficacy of cefazolin and cefmetazole in Staphylococcus aureus abscesses.
    Fields MT; Herndon BL; Bamberger DM
    Antimicrob Agents Chemother; 1993 Feb; 37(2):203-6. PubMed ID: 8452349
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The antibacterial activity of amoxycillin/clavulanic acid against Staphylococcus aureus ingested by human granulocytes.
    Cuffini AM; Tullio V; Allocco A; Paizis G; Carlone NA
    Microbios; 1996; 87(350):31-8. PubMed ID: 8972100
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cefotaxime and desacetylcefotaxime pharmacokinetics in very low birth weight neonates.
    Kearns GL; Jacobs RF; Thomas BR; Darville TL; Trang JM
    J Pediatr; 1989 Mar; 114(3):461-7. PubMed ID: 2921690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Detection of borderline oxacillin-resistant Staphylococcus aureus and differentiation from methicillin-resistant strains.
    Liu H; Buescher G; Lewis N; Snyder S; Jungkind D
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):717-24. PubMed ID: 2261916
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination.
    Jalil A; Niazi ID; Khan SU
    J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.